Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Apr 30:16:1203-1214.
doi: 10.2147/COPD.S301579. eCollection 2021.

Adherence and Efficacy of Smoking Cessation Treatment Among Patients with COPD in China

Rui Qin  1   2   3   4   5   6 , Zhao Liu  1   3   4   5   6 , Xinmei Zhou  1   3   4   5   6 , Anqi Cheng  1   3   4   5   6 , Ziyang Cui  1   3   4   5   6   7 , Jinxuan Li  1   3   4   5   6   8 , Xiaowen Wei  1   3   4   5   6   8 , Dan Xiao  1   3   4   5   6 , Chen Wang  1   3   4   5   6   7
Affiliations
Randomized Controlled Trial

Adherence and Efficacy of Smoking Cessation Treatment Among Patients with COPD in China

Rui Qin et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: Smoking cessation is a key intervention for all smokers with chronic obstructive pulmonary disease (COPD). Poor treatment adherence is a challenge in clinical practice that might contribute to the lower efficacy of medication (eg, oral drug). However, it is unclear what factors will influence adherence among smokers with COPD.

Methods: This study was based on an open-label randomized controlled trial (RCT) of varenicline and bupropion for smoking cessation among patients with COPD in China. The medication was given for 12 weeks, and visits and assessments were conducted at weeks 0, 1, 2, 4, 6, 9, 12, and 24. We assessed whether the adherence to smoking cessation treatment affects the smoking cessation efficacy and evaluated predictors of adherence.

Results: A total of 136 participants were recruited from February 2019 to June 2020, and analyzed using the intention-to-treat (ITT) method. In this study, 48.5% (66/136) of the total participants had good adherence to smoking cessation, and good adherence significantly improved the efficacy of smoking cessation (OR=9.60, 95% CI 4.02-22.96, P < 0.001). After adjusting for age, gender, nationality, education, and marital status, we found older age, higher education level, having more previous quitting attempts, stronger self-efficacy and preparation in quitting smoking, recognizing hazards of smoking, longer duration of COPD, and higher St. George's Respiratory Questionnaire (SGRQ) scores were relevant to good adherence (P < 0.05).

Conclusion: To our best knowledge, this is the first study to evaluate adherence to smoking cessation treatment among patients with COPD in China. Our study found that good adherence to smoking cessation treatment significantly improved the smoking cessation efficacy, and predictors of adherence were evaluated. We call on the medical community to pay attention to the adherence to smoking cessation among patients with COPD.

Keywords: COPD; China; adherence; smoking cessation.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flowchart of participants.
Figure 2
Figure 2
Comparison of abstinence rate between varenicline and bupropion at different time points.
Figure 3
Figure 3
Adherence to smoking cessation treatment and its relationship with medication use and the efficacy of smoking cessation.
See this image and copyright information in PMC

References

    1. The GOLD Science Commitee. Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease (2021 REPORT); 2020. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.0-16.... Accessed November18, 2020.
    1. World Health Organization. The top 10 causes of death; 2018. Available from: http://www.who.int/en/newsroom/fact-sheets/detail/the-top-10-causes-of-d.... Accessed November28, 2020.
    1. Shelley D, Tseng TY, Gonzalez M, et al. Correlates of adherence to varenicline among HIV+ smokers. Nicotine Tob Res. 2015;17(8):968–974. doi: 10.1093/ntr/ntv068 - DOI - PMC - PubMed
    1. Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi: 10.1016/S0140-6736(18)30841-9 - DOI - PubMed
    1. Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. doi: 10.1002/14651858.CD008286.pub3 - DOI - PMC - PubMed

Publication types

MeSH terms